Lumos Diagnostics Holdings Limited (ASX:LDX)
Australia · Delayed Price · Currency is AUD 0.1250
0.00 (0.00%)
Aug 7, 2026, 4:10 PM AEST
ASX:LDX Market Cap
ASX:LDX has a market cap or net worth of 118.05 million as of August 7, 2026. Its market cap has increased by 73.31% in one year.
Market Cap
118.05M
Enterprise Value
123.26M
Revenue
18.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.13
ChartMarket Cap Chart
Since July 5, 2021, ASX:LDX's market cap has decreased from 196.70M to 118.05M, a decrease of -39.99%. That is a compound annual growth rate of -9.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 118.05M | -47.38% |
| Dec 31, 2025 | 224.36M | 756.38% |
| Dec 31, 2024 | 26.20M | -25.44% |
| Dec 29, 2023 | 35.13M | 248.53% |
| Dec 30, 2022 | 10.08M | -93.27% |
| Dec 31, 2021 | 149.80M | -23.85% |
| Jul 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| EBR Systems | 210.89M |
| Aroa Biosurgery | 195.43M |
| EMVision Medical Devices | 150.59M |
| Saluda Medical | 139.87M |
| SomnoMed | 92.01M |
| Cyclopharm | 69.97M |
| Epiminder | 69.23M |
| Compumedics | 46.94M |